(WKL) Wolters Kluwer - Ratings and Ratios
Software, Solutions, Health, Tax, Compliance
Description: WKL Wolters Kluwer
Wolters Kluwer N.V. (AS:WKL) is a global provider of professional information, software and services, operating across five segments: Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG. Its offerings span clinical decision-support tools, tax-and-audit automation platforms, compliance solutions for banks and insurers, regulatory workflow software, and enterprise ESG reporting systems.
In the Health segment, the company leverages AI-driven clinical technology to serve hospitals, payers and digital-health firms, capitalising on the post-pandemic surge in telemedicine and value-based care models. The Tax & Accounting segment benefits from increasing regulatory complexity and the shift toward cloud-based tax compliance, while the Financial & Corporate Compliance unit addresses tighter banking-product regulations worldwide.
The Legal & Regulatory segment targets law firms and corporate legal departments confronting expanding data-privacy and ESG-related mandates, and the Corporate Performance & ESG segment provides software that integrates financial reporting with sustainability metrics-an area driven by mandatory ESG disclosures in Europe and North America.
Key financial indicators from the most recent fiscal year show revenue of €5.1 billion, a 6 % YoY increase, and an adjusted EBIT margin of 23 %, reflecting strong pricing power in high-growth niche markets. The company’s free-cash-flow conversion remains above 70 %, supporting ongoing M&A activity and dividend sustainability.
Analysts should monitor macro-drivers such as global healthcare spending growth (projected ~5 % CAGR) and the acceleration of digital compliance solutions, which together underpin Wolters Kluwer’s long-term growth narrative.
For a deeper, data-driven valuation perspective, consider exploring Wolters Kluwer’s profile on ValueRay to see how its fundamentals stack up against sector peers.
WKL Stock Overview
| Market Cap in USD | 29,060m |
| Sub-Industry | Diversified Support Services |
| IPO / Inception |
WKL Stock Ratings
| Growth Rating | -4.27% |
| Fundamental | 80.5% |
| Dividend Rating | 62.5% |
| Return 12m vs S&P 500 | -38.7% |
| Analyst Rating | - |
WKL Dividends
| Dividend Yield 12m | 2.21% |
| Yield on Cost 5y | 3.69% |
| Annual Growth 5y | 14.82% |
| Payout Consistency | 99.1% |
| Payout Ratio | 45.8% |
WKL Growth Ratios
| Growth Correlation 3m | -51.1% |
| Growth Correlation 12m | -81% |
| Growth Correlation 5y | 91.8% |
| CAGR 5y | 5.29% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.13 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.67 |
| Sharpe Ratio 12m | -1.04 |
| Alpha | -35.16 |
| Beta | 0.219 |
| Volatility | 17.24% |
| Current Volume | 547.7k |
| Average Volume 20d | 716.4k |
| Stop Loss | 108 (-3%) |
| Signal | 0.14 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (1.58b TTM) > 0 and > 6% of Revenue (6% = 506.2m TTM) |
| FCFTA 0.23 (>2.0%) and ΔFCFTA 11.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -12.53% (prev -16.99%; Δ 4.46pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.25 (>3.0%) and CFO 2.46b > Net Income 1.58b (YES >=105%, WARN >=100%) |
| Net Debt (4.06b) to EBITDA (2.70b) ratio: 1.50 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (231.4m) change vs 12m ago -6.71% (target <= -2.0% for YES) |
| Gross Margin 68.71% (prev 69.16%; Δ -0.45pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 89.66% (prev 56.03%; Δ 33.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 53.13 (EBITDA TTM 2.70b / Interest Expense TTM 38.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.35
| (A) -0.11 = (Total Current Assets 2.61b - Total Current Liabilities 3.67b) / Total Assets 9.73b |
| (B) 0.14 = Retained Earnings (Balance) 1.36b / Total Assets 9.73b |
| (C) 0.21 = EBIT TTM 2.02b / Avg Total Assets 9.41b |
| (D) 0.15 = Book Value of Equity 1.36b / Total Liabilities 8.85b |
| Total Rating: 1.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.53
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 7.76% = 3.88 |
| 3. FCF Margin 26.64% = 6.66 |
| 4. Debt/Equity 5.64 = -2.50 |
| 5. Debt/Ebitda 1.50 = 0.95 |
| 6. ROIC - WACC (= 23.60)% = 12.50 |
| 7. RoE 110.4% = 2.50 |
| 8. Rev. Trend 73.08% = 5.48 |
| 9. EPS Trend -18.81% = -0.94 |
What is the price of WKL shares?
Over the past week, the price has changed by +1.27%, over one month by -1.94%, over three months by -19.11% and over the past year by -28.63%.
Is Wolters Kluwer a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WKL is around 94.46 EUR . This means that WKL is currently overvalued and has a potential downside of -15.17%.
Is WKL a buy, sell or hold?
What are the forecasts/targets for the WKL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 149.8 | 34.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 102.7 | -7.8% |
WKL Fundamental Data Overview
Market Cap EUR = 24.92b (24.92b EUR * 1.0 EUR.EUR)
P/E Trailing = 22.9307
P/E Forward = 20.0401
P/S = 4.1015
P/B = 28.9978
P/EG = 2.1788
Beta = 0.219
Revenue TTM = 8.44b EUR
EBIT TTM = 2.02b EUR
EBITDA TTM = 2.70b EUR
Long Term Debt = 4.45b EUR (from longTermDebt, last quarter)
Short Term Debt = 547.0m EUR (from shortLongTermDebt, last quarter)
Debt = 5.00b EUR (Calculated: Short Term 547.0m + Long Term 4.45b)
Net Debt = 4.06b EUR (from netDebt column, last quarter)
Enterprise Value = 28.98b EUR (24.92b + Debt 5.00b - CCE 942.0m)
Interest Coverage Ratio = 53.13 (Ebit TTM 2.02b / Interest Expense TTM 38.0m)
FCF Yield = 7.76% (FCF TTM 2.25b / Enterprise Value 28.98b)
FCF Margin = 26.64% (FCF TTM 2.25b / Revenue TTM 8.44b)
Net Margin = 18.72% (Net Income TTM 1.58b / Revenue TTM 8.44b)
Gross Margin = 68.71% ((Revenue TTM 8.44b - Cost of Revenue TTM 2.64b) / Revenue TTM)
Gross Margin QoQ = 64.22% (prev 71.49%)
Tobins Q-Ratio = 2.98 (Enterprise Value 28.98b / Total Assets 9.73b)
Interest Expense / Debt = 0.28% (Interest Expense 14.0m / Debt 5.00b)
Taxrate = 21.93% (148.0m / 675.0m)
NOPAT = 1.58b (EBIT 2.02b * (1 - 21.93%))
Current Ratio = 0.71 (Total Current Assets 2.61b / Total Current Liabilities 3.67b)
Debt / Equity = 5.64 (Debt 5.00b / totalStockholderEquity, last quarter 887.0m)
Debt / EBITDA = 1.50 (Net Debt 4.06b / EBITDA 2.70b)
Debt / FCF = 1.81 (Net Debt 4.06b / FCF TTM 2.25b)
Total Stockholder Equity = 1.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.22% (Net Income 1.58b / Total Assets 9.73b)
RoE = 110.4% (Net Income TTM 1.58b / Total Stockholder Equity 1.43b)
RoCE = 34.31% (EBIT 2.02b / Capital Employed (Equity 1.43b + L.T.Debt 4.45b))
RoIC = 29.32% (NOPAT 1.58b / Invested Capital 5.38b)
WACC = 5.72% (E(24.92b)/V(29.93b) * Re(6.82%) + D(5.00b)/V(29.93b) * Rd(0.28%) * (1-Tc(0.22)))
Discount Rate = 6.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -3.21%
[DCF Debug] Terminal Value 79.58% ; FCFE base≈1.78b ; Y1≈1.95b ; Y5≈2.49b
Fair Price DCF = 189.7 (DCF Value 43.33b / Shares Outstanding 228.4m; 5y FCF grow 11.08% → 3.0% )
EPS Correlation: -18.81 | EPS CAGR: -72.59% | SUE: 0.0 | # QB: 0
Revenue Correlation: 73.08 | Revenue CAGR: 64.80% | SUE: -0.02 | # QB: 0